Werewolf Therapeutics’ hunt for…
Werewolf Therapeutics’ hunt for strategic alternatives has ended. Ambros Therapeutics [...]
Werewolf Therapeutics’ hunt for strategic alternatives has ended. Ambros Therapeutics [...]
Boehringer Ingelheim has suspended a phase 1 trial of an [...]
Joshua Pinto, Ph.D., has been appointed chief executive officer of [...]
Eli Lilly has turned to one of its Gateway Labs [...]
As the dust settles on phase 3 data that added [...]
Pheast Therapeutics may have learned the hard way about the [...]
TScan has told Fierce that its pipeline strategy remains unchanged [...]
After three months without a permanent leader in place, President [...]
Tolerance Bio has vaulted into the clinic by agreeing to [...]
Merck & Co. and Moderna’s personalized mRNA cancer vaccine has [...]